Tarceva
Product Images NDC 54868-5447

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tarceva (NDC 54868-5447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 25 mg Package Label (5290)

This is a prescription drug labeled TARCEVA 25MG, distributed by PHYSICIANS TOTAL CARE in a package containing 30 tablets. The package has a LOT# 000 and an expiration date of 01/60. The NDC number is 54868-5290-0. The last line "S2900300000" is not a part of the label description and its meaning cannot be determined from the available text.*

FDA Label Image

Image Of 150 mg Package Label (5447)

This appears to be information from a medication package. The medication is called Tarceva, with a strength of 150g, and the package contains 30 tablets. It was distributed by Physicians Total Care and has an NDC code of 54868-5447-6. The lot number is 6000 and the expiration date is 01/60. The other text "Tse, 0% Feide" and "54470300000" do not appear to be relevant to the medication description.*

FDA Label Image

Image Of 100 mg Package Label (5474)

This appears to be the label of Tarceva - a medication distributed by Physicians Total Care. The medication is in the form of 30 tablets and has an NDC code of 54868-5474-0. The lot number mentioned is 0066 with an expiration date of 01/60. However, the purpose of this medication is not clear.*

FDA Label Image

Image Of Chemical Formula (Tarceva 01)

FDA Label Image

Image Of Figure 1 (Tarceva 02)

The text describes a Kaplan-Meler Curve for the overall survival of patients by treatment group. The graph includes a survival probability chart with time in months on the x-axis and survival probability on the y-axis. The groups being compared are the placebo group and those who were treated with Medlan for a duration of 4.7 months. The curves show the survival time of patients in each group over a period of 30 months.*

FDA Label Image

Image Of Figure 2 (Tarceva 03)

FDA Label Image

Image Of Genetech Logo (Tarceva 04)

FDA Label Image

Image Of Osi Logo (Tarceva 05)

This text is too short and incomplete to provide a useful description. It only contains the word "oncology", which refers to the medical specialty dealing with the prevention, diagnosis, and treatment of cancer.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.